GenoFocus Inc (187420) — Capital Reinvestment Ratio
GenoFocus Inc (187420) has a Capital Reinvestment Ratio of 0.48x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩288.09 Million) in capital expenditures (₩138.88 Million). Check tangible equity quality of GenoFocus Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GenoFocus Inc Capital Reinvestment Ratio (2015–2025)
This chart tracks GenoFocus Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see GenoFocus Inc (187420) cash flow conversion.
Annual Capital Reinvestment Ratio for GenoFocus Inc (2015–2025)
Year-by-year Capital Reinvestment Ratio for GenoFocus Inc from 2015 to 2025. See GenoFocus Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | ₩3.50 Billion | ₩1.08 Billion | ▲ +26.1% |
| 2024 | 0.24x | ₩2.87 Billion | ₩699.16 Million | ▼ -94.9% |
| 2018 | 4.74x | ₩1.56 Billion | ₩7.42 Billion | ▲ +213.4% |
| 2017 | 1.51x | ₩1.36 Billion | ₩2.06 Billion | ▼ -85.7% |
| 2016 | 10.58x | ₩516.09 Million | ₩5.46 Billion | ▲ +270.9% |
| 2015 | 2.85x | ₩2.85 Billion | ₩8.14 Billion | — |